ArticleFrontiers in public health2025
Global, regional, and national burden of spinal cord lesion at neck level a systematic analysis of incidence, prevalence, YLDs with projections to 2046.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Spinal cord lesion at neck level imposes significant global morbidity, yet cervical-specific burden analysis remains limited. Methods: Using Global Burden of Disease (GBD) 2021 data (1990-2021), we analyzed incidence, prevalence, and years lived with disability (YLDs) across 204 countries/territories, stratified by sex, age, socio-demographic index (SDI) regions, GBD super regions, and countries. Age-period-cohort (APC) model and Bayesian age-period-cohort (BAPC) model projected trends to 2046. Results: In 2021, global incidence was 306,568 (age-standardized incidence rate [ASIR] 3.78/100,000), prevalence 7.42 million (age-standardized prevalence rate [ASPR] 88.47/100,000), and YLDs 2.91 million (age-standardized YLDs rate [ASYLDR] 34.72/100,000). Males had higher burdens than females, with cases peaking at 45-64 years. Middle-SDI regions had the highest absolute cases (79,611 incidence), while high-SDI regions showed the highest age-standardized rates (ASRs) (ASIR 5.86/100,000). From 1990-2021, absolute cases rose, but ASRs declined. Projections predict rising absolute cases through 2046. Conclusion: This study reveals marked regional and demographic disparities in cervical spinal cord lesion burden. Targeted prevention and healthcare planning in high-burden regions are essential to address this global health challenge.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.